Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

被引：0
|
作者：
Boussion, H. [1 ]
Hammel, P. [2 ]
机构：
[1] AERIO, Tokyo, Japan
[2] Hop Beaujon, Clichy, France
来源：
ONCOLOGIE | 2015年 / 17卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：59 / 60
页数：2
相关论文
共 50 条
  • [21] Ultra-high-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumors
    Faiss, S
    Räth, U
    Mansmann, U
    Caird, D
    Clemens, N
    Riecken, EO
    Wiedenmann, B
    DIGESTION, 1999, 60 (05) : 469 - 476
  • [22] Can PPH3 be helpful to assess the discordant grade in primary and metastatic enteropancreatic neuroendocrine tumors?
    Dumars, Clotilde
    Foubert, Fanny
    Touchefeu, Yann
    Regenet, Nicolas
    Senellart, Helene
    Matysiak-Budnik, Tamara
    Heymann, Marie-Francoise
    ENDOCRINE, 2016, 53 (02) : 395 - 401
  • [23] Real world use of lanreotide in neuroendocrine tumors
    Siddiqui, Zeba
    Marginean, Horia
    Leung, Macyn
    Asmis, Timothy
    Vickers, Michael
    Goodwin, Rachel
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (03) : 1488 - 1495
  • [24] Can PPH3 be helpful to assess the discordant grade in primary and metastatic enteropancreatic neuroendocrine tumors?
    Clotilde Dumars
    Fanny Foubert
    Yann Touchefeu
    Nicolas Regenet
    Hélène Senellart
    Tamara Matysiak-Budnik
    Marie-Françoise Heymann
    Endocrine, 2016, 53 : 395 - 401
  • [25] Economic Evaluation of Octreotide LAR versus Lanreotide Depot in the Treatment of Metastatic Gastrointestinal Neuroendocrine Tumors
    Ayyagari, Rajeev
    Neary, Maureen
    Li, Shang
    Zhao, Chen
    Higuchi, Keiko
    Xie, Jipan
    Benson, Al B., III
    PANCREAS, 2016, 45 (03) : 471 - 472
  • [26] Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide
    Ricci, S
    Antonuzzo, A
    Galli, L
    Ferdeghini, M
    Bodei, L
    Orlandini, C
    Conte, PF
    ANNALS OF ONCOLOGY, 2000, 11 (09) : 1127 - 1130
  • [27] Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors
    Grenader, Tal
    Pavel, Marianne E.
    Ruszniewski, Philippe B.
    Cwikla, Jaroslaw B.
    Phan, Alexandria T.
    Raderer, Markus
    Sedlackova, Eva
    Cadiot, Guillaume
    Wolin, Edward M.
    Capdevila, Jaume
    Wall, Lucy
    Rindi, Guido
    Xuan-Mai Truong Thanh
    Caplin, Martyn E.
    ANTI-CANCER DRUGS, 2020, 31 (03) : 216 - 222
  • [28] Efficacy of Lanreotide in metastatic neuroendocrine Tumor of the Gastrointestinal Tract
    Schmitz, F.
    GASTROENTEROLOGE, 2014, 9 (05): : 470 - 471
  • [29] Real World Use of Lanreotide in Management of Neuroendocrine Tumors
    Siddiqui, Zeba
    Marginean, Horia
    Asmis, Timothy
    Vickers, Michael
    Goodwin, Rachel
    PANCREAS, 2022, 51 (03) : E38 - E38
  • [30] Is lanreotide and/or interferon alfa an adequate therapy for neuroendocrine tumors?
    Völter, V
    Peschel, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) : 573 - 573
12345